Alexion Pharmaceuticals,Inc.
Global Access & Pricing Lead, Amyloidosis
Alexion Pharmaceuticals,Inc., Boston, Massachusetts, us, 02298
Location: Boston, United States
Job reference: R-210185
Date posted: 10/03/2024
At Alexion, AstraZeneca Rare Disease, we are innovators, leaders, and collaborators. At the heart of everything we do is an intense desire to pursue the toughest challenges and truly change the world for people living with rare and devastating diseases.
At Alexion, AstraZeneca Rare Disease, people living with rare and devastating diseases are our Guiding Star. We are driven to continuously innovate and create meaningful value in all we do to help patients and families fully live their best lives. We value the uniqueness and diversity of our employees and recognize that nurturing the diverse perspectives and strengths of our people translate into innovation breakthroughs for patients.
Why the job exists:
Amyloidosis Alexion Rare diseases portfolio through successful launch of CAEL, Acoramidis and ALXN 2220 pipeline asset is a central component to realization of Alexion 2030 ambition.
Our corresponding ability to “flex” Amyloidosis Global Access & Pricing strategy to the highly competitive disease environment together with a clear strategic pricing alignment to AZ portfolio Amyloidosis assets will be key to achieving above ambition.
It is therefore an imperative that our Amyloidosis Global Access-Pricing strategy and capabilities integrate the disease portfolio complexity, the competitive market environment and the diversity of our global geography footprint to enable timely market access and reimbursement at optimal pricing potential.
This is what you will do:
Join a highly valued, strategic team that is fundamental in realizing the potential of our life-changing medicines. It’s through our work that AstraZeneca is able to ensure the right access is provided to our transformative medicines.
Alexion AstraZeneca’s Rare Disease GVAP team is seeking a qualified candidate to be part of a dynamic and growing team with responsibility for Amyloidosis portfolio, including ready to be launched late phase as well as early pipeline assets.
You will be responsible for:
GLOBAL VALUE, ACCESS AND PRICING, LEAD:
Value
Ability to lead across function development of a clear differentiated asset value proposition while influencing without authority and navigating complex organizational systems.
Influence the development of Clinical Development Programs to ensure that endpoints and evidence generation plans (i.e. clinical, economic, and humanistic outcomes) are incorporated to support optimized patient access.
Lead and Secure timely country input into Amyloidosis Clinical Development Programs to ensure that endpoints and evidence generation plans are matching payer needs in priority target countries.
Provide support to GMMA commercial team in informing early asset development, particularly through early governance milestones focused on market access potential, evidence, and TPP requirements.
Access
Lead the assessment of P&R risks and opportunities specific to amyloidosis portfolio.
Close collaboration with target key countries and support global functions (HeoR, medical, commercial), Lead development of global reimbursement dossier and overall across function market access readiness amyloidosis portfolio plans.
Organize and manage multiple projects and regions, and prioritize tasks, while maintaining an understanding of national and global perspectives.
Pricing
Develop and propose Amyloidosis portfolio and individual assets pricing strategy.
Offer critical strategic inputs to inform access and pricing assumptions, creating accurate, market-driven LTP assumptions for pipeline assets in the context of amyloidosis.
Engage with senior leaders on critical business development opportunities by driving assessment of pricing and access strategies and coverage assumptions.
Communicate frequently and effectively with GMMA senior leadership, and other identified stakeholders, particularly in relation to amyloidosis portfolio pricing.
Create and roll out strategic value, access and pricing communication tools and materials to support local P&R submissions and negotiations such as pricing frameworks, negotiation strategy & toolkits, etc. per the enterprise-wide launch framework.
You will need to have:
Experience – capabilities & skills:
We are seeking a candidate with 10+ years pricing- market access experience working with US and/or EU-international markets in developing & implementing market access strategies-initiatives in a payer strategy function, e.g., managed markets brand director, pricing/access.
Experience in constructing asset value proposition, payer value narrative and incorporating these into TPPs with confirmed examples of success.
Experience working with clinicians, pharmacists, and payers on evidence-based customer solutions, e.g. through working with local payers in EU or commercial customers in the US.
Prior rare disease therapy area expertise with Relevant drug development and/or commercialization experience within the pharmaceutical/medical industry.
Several years of previous project leadership experience in the generation of payer evidence or development/execution of payer commercial strategies (e.g. Health Economics, Market Access, Pricing).
Capabilities & skills - This role requires:
Relevant Graduate degree e.g. PhD, PharmD, biomedical science, business, or economics.
Knowledge of the needs and expectations of national and regional payers, insurers, and commercial customers in our strategic markets.
Ability to build-mobilize positive relationships and effectively collaborate across functions (clinical, commercial, medical), seeking to understand and anticipate evolving internal and external payer priorities environment.
Engaged in problem solving and non-linear thought, analysis, and dialogue.
Highly autonomous and an effective communicator with cultural sensitivity and engagement skills across the diversity of EU/international markets in scope.
Ability to deal with complexity (Countries, portfolio, diseases).
The duties of this role are generally conducted in an office environment. As is typical of an office-based role, employees must be able, with or without an accommodation to use a computer; engage in communications via phone, video, and electronic messaging; with others; maintain general availability during standard business hours.
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.
#J-18808-Ljbffr
Job reference: R-210185
Date posted: 10/03/2024
At Alexion, AstraZeneca Rare Disease, we are innovators, leaders, and collaborators. At the heart of everything we do is an intense desire to pursue the toughest challenges and truly change the world for people living with rare and devastating diseases.
At Alexion, AstraZeneca Rare Disease, people living with rare and devastating diseases are our Guiding Star. We are driven to continuously innovate and create meaningful value in all we do to help patients and families fully live their best lives. We value the uniqueness and diversity of our employees and recognize that nurturing the diverse perspectives and strengths of our people translate into innovation breakthroughs for patients.
Why the job exists:
Amyloidosis Alexion Rare diseases portfolio through successful launch of CAEL, Acoramidis and ALXN 2220 pipeline asset is a central component to realization of Alexion 2030 ambition.
Our corresponding ability to “flex” Amyloidosis Global Access & Pricing strategy to the highly competitive disease environment together with a clear strategic pricing alignment to AZ portfolio Amyloidosis assets will be key to achieving above ambition.
It is therefore an imperative that our Amyloidosis Global Access-Pricing strategy and capabilities integrate the disease portfolio complexity, the competitive market environment and the diversity of our global geography footprint to enable timely market access and reimbursement at optimal pricing potential.
This is what you will do:
Join a highly valued, strategic team that is fundamental in realizing the potential of our life-changing medicines. It’s through our work that AstraZeneca is able to ensure the right access is provided to our transformative medicines.
Alexion AstraZeneca’s Rare Disease GVAP team is seeking a qualified candidate to be part of a dynamic and growing team with responsibility for Amyloidosis portfolio, including ready to be launched late phase as well as early pipeline assets.
You will be responsible for:
GLOBAL VALUE, ACCESS AND PRICING, LEAD:
Value
Ability to lead across function development of a clear differentiated asset value proposition while influencing without authority and navigating complex organizational systems.
Influence the development of Clinical Development Programs to ensure that endpoints and evidence generation plans (i.e. clinical, economic, and humanistic outcomes) are incorporated to support optimized patient access.
Lead and Secure timely country input into Amyloidosis Clinical Development Programs to ensure that endpoints and evidence generation plans are matching payer needs in priority target countries.
Provide support to GMMA commercial team in informing early asset development, particularly through early governance milestones focused on market access potential, evidence, and TPP requirements.
Access
Lead the assessment of P&R risks and opportunities specific to amyloidosis portfolio.
Close collaboration with target key countries and support global functions (HeoR, medical, commercial), Lead development of global reimbursement dossier and overall across function market access readiness amyloidosis portfolio plans.
Organize and manage multiple projects and regions, and prioritize tasks, while maintaining an understanding of national and global perspectives.
Pricing
Develop and propose Amyloidosis portfolio and individual assets pricing strategy.
Offer critical strategic inputs to inform access and pricing assumptions, creating accurate, market-driven LTP assumptions for pipeline assets in the context of amyloidosis.
Engage with senior leaders on critical business development opportunities by driving assessment of pricing and access strategies and coverage assumptions.
Communicate frequently and effectively with GMMA senior leadership, and other identified stakeholders, particularly in relation to amyloidosis portfolio pricing.
Create and roll out strategic value, access and pricing communication tools and materials to support local P&R submissions and negotiations such as pricing frameworks, negotiation strategy & toolkits, etc. per the enterprise-wide launch framework.
You will need to have:
Experience – capabilities & skills:
We are seeking a candidate with 10+ years pricing- market access experience working with US and/or EU-international markets in developing & implementing market access strategies-initiatives in a payer strategy function, e.g., managed markets brand director, pricing/access.
Experience in constructing asset value proposition, payer value narrative and incorporating these into TPPs with confirmed examples of success.
Experience working with clinicians, pharmacists, and payers on evidence-based customer solutions, e.g. through working with local payers in EU or commercial customers in the US.
Prior rare disease therapy area expertise with Relevant drug development and/or commercialization experience within the pharmaceutical/medical industry.
Several years of previous project leadership experience in the generation of payer evidence or development/execution of payer commercial strategies (e.g. Health Economics, Market Access, Pricing).
Capabilities & skills - This role requires:
Relevant Graduate degree e.g. PhD, PharmD, biomedical science, business, or economics.
Knowledge of the needs and expectations of national and regional payers, insurers, and commercial customers in our strategic markets.
Ability to build-mobilize positive relationships and effectively collaborate across functions (clinical, commercial, medical), seeking to understand and anticipate evolving internal and external payer priorities environment.
Engaged in problem solving and non-linear thought, analysis, and dialogue.
Highly autonomous and an effective communicator with cultural sensitivity and engagement skills across the diversity of EU/international markets in scope.
Ability to deal with complexity (Countries, portfolio, diseases).
The duties of this role are generally conducted in an office environment. As is typical of an office-based role, employees must be able, with or without an accommodation to use a computer; engage in communications via phone, video, and electronic messaging; with others; maintain general availability during standard business hours.
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.
#J-18808-Ljbffr